Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes
Lung cancer innovation at the agency is looking at technology to improve detection and treatment.
-
Dr. Michael Kelley National Program Director for Oncology VA
-
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
Federal Agencies Make the Case for Quantum
Amid development of emerging technologies like AI and machine learning, leaders see promise in quantum computing.
6m read -
NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
32m listen -
Cyber Resilience and Recovery Amid Evolving Cyber Threats
Data durability is a key aspect of NIST’s cybersecurity framework for public and private organizations.
21m listen -
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen